EP1621212 - Bibliographic data
Formulations comprising antisense nucleotides to connexins
| Last update | 23/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
CODA THERAPEUTICS, INC. 10505 Sorrento Valley Road, Suite 395
San Diego, CA 92121
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Becker David. Dr 19 Lapwing Way
Abbots Langley Hertfordshire WD5 0GG
Royaume-Uni
Green Colin R. Dr 3/4 Cresent Road
Epsom Auckland
Nouvelle-Zélande
|
| (74) Agent |
Mail recipient
OPILEX 32, Rue Victor Lagrange
69007
Lyon
France
|
| (21) Request number | EP05016736.0 |
|---|---|
| (22) Request date | 27/01/2000 |
| (11) Publication number | EP1621212 |
|---|---|
| Publication date | 16/11/2011 |
| (54) Title of the invention | Formulations comprising antisense nucleotides to connexins |
|---|---|
| (51) International classification | A61K 48/00, A61K 31/70, C12N 15/11, A61P 17/02 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 33392899
(31) Number: 50019099 |
|---|---|
| Initial application | None |
| Divisional application | EP10013180.4 /EP2314321 None |
| Expected annuity |
Annuity: 20 -
Amount: 400 € -
Due date 31/01/2019
Surtax: 20 - Amount: 80 € - Due date 01/08/2019 |
|---|---|
| Last annuity | Annuity: 19 - Payment date 24/01/2018 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2011/4, of 31/12/2011 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 16/11/2011 Constitution de mandataire pour un dossier - Legal date 06/02/2012 Entrée en période de grâce du brevet d'invention - Legal date 01/02/2019 Génération de l'avertissement avant déchéance - Legal date 18/02/2019 Déchéance du brevet d'invention après période de grâce - Legal date 31/01/2019 |